Form 4: INSMED CFO Sells Shares for Tax Obligations

INSMED Inc.'s Chief Financial Officer, Sara Bonstein, sold shares of common stock totaling 4,642 units over three days in January 2026 to cover tax withholding and broker fees.

Summary

• Sara Bonstein, Chief Financial Officer of INSMED Inc., sold a total of 4,642 shares of common stock.
• The sales occurred on January 6, 7, and 8, 2026.
• On January 6, 2026, 1,517 shares were sold at $173.33 per share, leaving 83,631 shares beneficially owned.
• On January 7, 2026, 1,678 shares were sold at $175.07 per share, leaving 81,953 shares beneficially owned.
• On January 8, 2026, 1,447 shares were sold at $174.17 per share, leaving 80,506 shares beneficially owned.
• These transactions were executed to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-planned.

Sentiment

Score: 5

Explanation: The filing reports routine insider stock sales for tax withholding purposes, which is a neutral event and does not indicate a change in company fundamentals or management's confidence.

Positives

• The transactions were pre-planned under a Rule 10b5-1(c) plan, indicating a structured and compliant approach to managing equity compensation.

Negatives

• No specific negatives are indicated by these routine tax-related sales.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

NA

Industry Context

This Form 4 filing details an individual insider transaction and does not provide information relevant to broader industry trends or competitive landscape.

Stakeholder Impact

• Minimal impact on shareholders, as these are routine, pre-planned sales for tax purposes and do not signal a change in company prospects.
• No direct impact on employees, customers, suppliers, or creditors is indicated.

Key Dates

Recommendation

The reported transactions are routine sales by a corporate officer to cover tax obligations associated with the vesting of Restricted Stock Units, executed under a pre-arranged 10b5-1 plan. Such sales are common and generally do not reflect a change in the officer's confidence in the company's future or its operational performance. Therefore, this filing alone does not provide a basis for a change in investment recommendation; a 'hold' stance is maintained pending further fundamental analysis.

Keywords

INSMED Inc., INSM, Sara Bonstein, CFO, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation, Rule 10b5-1